Moderate intensity exercise significantly boosts endocannabinoids and improves mood for those with major depressive disorder.
The antidepressant effect of psilocybin-assisted therapy, in combination with psychotherapy, appears to provide up to a year of symptom relief for some patients with major depressive disorder.
Study finds an association between resting state network connectivity abnormalities in those with major depressive disorder who experienced childhood trauma.
Researchers have discovered a link between specific neural circuits to distinct behavioral symptoms of depression. The study, published in Cell, reports altering the networks helped to improve symptoms such as social withdrawal and helplessness.
Differences in the expression of gene transcripts shed light on how mental health disorders with shared genetic risk factors differ in onset, symptoms, course of progression, and treatment responses.
A genetic liability for major depression increases suicide risk across other psychiatric disorders.
Comparing data from multiple neuroimaging studies, researchers found shared brain structural abnormalities between four psychiatric disorders, including schizophrenia and bipolar disorder. They also identified brain signatures unique to each condition.
A new study reports on the role a microRNA plays in major depressive disorder.
In a new study using rat models, researchers report adding a certain lactic acid bacteria to the diet can help to prevent a type of depression linked to an unhealthy lifestyle.
Findings provide evidence to support the role of human roseoloviruses, HHV-6A, and HHV-6B in bipolar disorder and major depressive disorder.
Using data from neuroimaging, a machine learning algorithm has identified key functional neural connections that could serve as a biomarker in the diagnosis of major depressive disorder.
A new substance named Lu AF60097 may help reduce side effects from tricyclic antidepressants in those with severe depression.
